These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection. Solanky D; Pardi DS; Loftus EV; Khanna S Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451 [TBL] [Abstract][Full Text] [Related]
23. Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients. Tschudin-Sutter S; Carroll KC; Tamma PD; Sudekum ML; Frei R; Widmer AF; Ellis BC; Bartlett J; Perl TM Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1324-9. PubMed ID: 26223207 [TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN study. Martinelli M; Strisciuglio C; Veres G; Paerregaard A; Pavic AM; Aloi M; Martín-de-Carpi J; Levine A; Turner D; Del Pezzo M; Staiano A; Miele E; Inflamm Bowel Dis; 2014 Dec; 20(12):2219-25. PubMed ID: 25268634 [TBL] [Abstract][Full Text] [Related]
25. Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute. Khanna S; Shin A; Kelly CP Clin Gastroenterol Hepatol; 2017 Feb; 15(2):166-174. PubMed ID: 28093134 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital. Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449 [TBL] [Abstract][Full Text] [Related]
27. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022 [TBL] [Abstract][Full Text] [Related]
28. Management of inflammatory bowel disease with D'Aoust J; Battat R; Bessissow T World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153 [TBL] [Abstract][Full Text] [Related]
29. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A; Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400 [TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703 [TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile infection in hospitalized patients with inflammatory bowel disease: Prevalence, risk factors, and prognosis. Maharshak N; Barzilay I; Zinger H; Hod K; Dotan I Medicine (Baltimore); 2018 Feb; 97(5):e9772. PubMed ID: 29384868 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of Clostridium difficile colonization at admission to rehabilitation. Marciniak C; Chen D; Stein AC; Semik PE Arch Phys Med Rehabil; 2006 Aug; 87(8):1086-90. PubMed ID: 16876554 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease. Dai C; Jiang M; Huang YH J Crohns Colitis; 2019 Mar; 13(3):395. PubMed ID: 30371802 [No Abstract] [Full Text] [Related]
34. Clostridium difficile Infection in Inflammatory Bowel Disease: A Nursing-Based Quality Improvement Strategy. Axelrad JE; Shah BJ J Healthc Qual; 2016; 38(5):283-9. PubMed ID: 26042744 [TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: prevalence and risk factors. Banaszkiewicz A; Kowalska-Duplaga K; Pytrus T; Pituch H; Radzikowski A Inflamm Bowel Dis; 2012 May; 18(5):844-8. PubMed ID: 21936029 [TBL] [Abstract][Full Text] [Related]
36. Risk factors for the development of Clostridium difficile infection in hospitalized children. Samady W; Pong A; Fisher E Curr Opin Pediatr; 2014 Oct; 26(5):568-72. PubMed ID: 25032717 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile and inflammatory bowel disease. Ananthakrishnan AN; Issa M; Binion DG Gastroenterol Clin North Am; 2009 Dec; 38(4):711-28. PubMed ID: 19913210 [TBL] [Abstract][Full Text] [Related]
38. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. Pascarella F; Martinelli M; Miele E; Del Pezzo M; Roscetto E; Staiano A J Pediatr; 2009 Jun; 154(6):854-8. PubMed ID: 19230908 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases. Horton N; Kochhar G; Patel K; Lopez R; Shen B Inflamm Bowel Dis; 2017 Jul; 23(7):1080-1087. PubMed ID: 28452863 [TBL] [Abstract][Full Text] [Related]